Pages
- 2017
- 2018
- 2019
- About Us
- Company Background
- Board of Directors
- Tan Sri Datin Paduka Siti Sa’diah Binti Sh Bakir
- Leonard Ariff Bin Abdul Shatar
- Amizar Binti Mizuar
- Dato’ Dr. Zaki Morad Bin Mohamad Zaher
- Dato’ Mohamad Kamarudin Bin Hassan
- Razalee Bin Amin
- Zaiton Binti Jamaluddin
- Dato’ Eisah Binti A. Rahman
- Datuk Nik Moustpha Bin Hj Nik Hassan
- Datuk Mohd Radzif Bin Mohd Yunus
- Group Structure
- Senior Management
- Board of Directors
- Shareholders Information
- Registrar
- Awards and Recognition
- Corporate Governance
- Constitution
- Directors Code Of Best Practice
- Management & Monitoring Framework
- Principle 1 (Establish Clear Roles & Responsibilities)
- Board Charter
- Code of Conduct
- Principle 2 (Strengthen Composition)
- Meeting of members
- Principle 5 (Uphold Integrity in Financial Reporting)
- Principle 7 (Ensure Timely & High Quality Disclosure)
- Principle 8 (Strengthen Relationship between Company & Shareholders)
- Terms of Reference
- Terms of Reference of the Halal Committee of Duopharma Biotech Berhad
- Terms of Reference of the Medical Advisory Committee
- Terms of Reference of the Audit and Integrity Committee of Duopharma Biotech Berhad
- Terms of Reference of the Nomination and Remuneration Committee of Duopharma Biotech Berhad
- Terms of Reference of the Risk Management and Sustainability Committee of Duopharma Biotech Berhad
- Halal Initiatives
- Policy and Procedure
- Policy and Procedures on the Remuneration for Directors and Senior Management
- Policy On External Auditors
- Shareholders and Investors Communication Policy
- Corporate Disclosure Policies & Procedures
- Corporate Social Responsibility (CSR) Policy
- Halal Policy
- Integrity Policies
- Anti-Bribery & Anti-Corruption Policy
- Anti-Bribery Management System
- Anti-Money Laundering & Counter Financing Terrorism Policy
- Business Ethics Policy
- Declaration of Interest Policy
- Gift & Hospitality Policy
- Honorarium Guidelines
- Integrity Pact Policy
- Investigation Procedure
- Sponsorship Policy
- Whistle-Blowing Policy
- Organisational Integrity and Anti-Corruption Plan 2021-2023
- Quality Policy
- Sustainability Policies
- Annual General Meeting
- Blog
- Cardiovascular
- Career Centre
- Champs
- Circular to Shareholders
- Circular to Shareholders
- Contact Information
- Corporate Disclosure Policy
- Dermatological
- Directors and Senior Management Remuneration Policy
- Email Disclaimer
- Ethical Classic
- Ethical Specialist
- Gallery
- General Anti-Infectives Systemic
- Genito-Urinary
- Home
- Investor Relations
- Meeting of members
- Musculo-Skeletal
- Nervous
- Notice of Annual General Meeting
- Notice of Meeting of Members
- Personal Data Protection Act
- Press Releases
- Principle 2 (Strengthen Composition)
- Proceeding and Minutes
- Proceeding and Minutes
- Product
- Respiratory
- Sensory Organs
- Sitemap
- Sustainability Report
- Systemic Hormonal
- Terms & Conditions
- Various
- Video
- Business Activities
- Corporate Governance Report